News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
770,954 Results
Type
Article (51656)
Company Profile (295)
Press Release (718991)
Multimedia
Podcasts (113)
Webinars (20)
Section
Business (213057)
Career Advice (2126)
Deals (36724)
Drug Delivery (140)
Drug Development (84191)
Employer Resources (174)
FDA (17348)
Job Trends (15852)
News (361152)
Policy (34934)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2831)
Accelerated approval (52)
Adcomms (32)
Allergies (182)
Alliances (51766)
ALS (224)
Alzheimer's disease (1878)
Antibody-drug conjugate (ADC) (497)
Approvals (17760)
Artificial intelligence (726)
Autoimmune disease (325)
Automation (59)
Bankruptcy (375)
Best Places to Work (12095)
BIOSECURE Act (20)
Biosimilars (226)
Biotechnology (186)
Bladder cancer (203)
Brain cancer (76)
Breast cancer (806)
Cancer (6217)
Cardiovascular disease (507)
Career advice (1815)
Career pathing (46)
CAR-T (348)
CDC (64)
Celiac Disease (3)
Cell therapy (942)
Cervical cancer (53)
Clinical research (73191)
Collaboration (2191)
Company closure (5)
Compensation (1445)
Complete response letters (85)
COVID-19 (2880)
CRISPR (113)
C-suite (1212)
Cystic fibrosis (155)
Data (8392)
Decentralized trials (3)
Denatured (41)
Depression (175)
Dermatology (94)
Diabetes (621)
Diagnostics (7212)
Digital health (61)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (337)
Drug pricing (212)
Drug shortages (34)
Duchenne muscular dystrophy (296)
Earnings (94400)
Editorial (71)
Employer branding (21)
Employer resources (153)
Events (125360)
Executive appointments (1128)
FDA (21281)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1813)
Gene editing (244)
Generative AI (64)
Gene therapy (748)
GLP-1 (1131)
Government (5031)
Grass and pollen (6)
Guidances (417)
Healthcare (20212)
HIV (85)
Huntington's disease (58)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (105)
Immunology and inflammation (299)
Immuno-oncology (102)
Indications (201)
Infectious disease (3245)
Inflammatory bowel disease (225)
Inflation Reduction Act (14)
Influenza (141)
Intellectual property (302)
Interviews (327)
IPO (17038)
IRA (51)
Job creations (4063)
Job search strategy (1510)
JPM (58)
Kidney cancer (19)
Labor market (105)
Layoffs (587)
Leadership (42)
Legal (8512)
Liver cancer (106)
Longevity (34)
Lung cancer (836)
Lymphoma (447)
Machine learning (62)
Management (59)
Manufacturing (1104)
MASH (208)
Medical device (14997)
Medtech (15140)
Mergers & acquisitions (20961)
Metabolic disorders (1611)
mRNA (230)
Multiple sclerosis (195)
NASH (17)
Neurodegenerative disease (455)
Neuropsychiatric disorders (112)
Neuroscience (3492)
Neurotech (1)
NextGen: Class of 2026 (6923)
Non-profit (4795)
Now hiring (79)
Obesity (755)
Opinion (308)
Ovarian cancer (237)
Pain (266)
Pancreatic cancer (333)
Parkinson's disease (389)
Partnered (34)
Patents (616)
Patient recruitment (717)
Peanut (66)
People (62645)
Pharmaceutical (64)
Pharmacy benefit managers (34)
Phase 1 (22799)
Phase 2 (32166)
Phase 3 (23994)
Pipeline (9365)
Policy (333)
Postmarket research (2747)
Preclinical (9726)
Press Release (67)
Prostate cancer (330)
Psychedelics (58)
Radiopharmaceuticals (349)
Rare diseases (1133)
Real estate (6372)
Recruiting (70)
Regulatory (27079)
Reports (56)
Research institute (2584)
Resumes & cover letters (363)
Rett syndrome (39)
RNA editing (23)
RSV (91)
Schizophrenia (187)
Series A (303)
Series B (221)
Service/supplier (12)
Sickle cell disease (119)
Special edition (24)
Spinal muscular atrophy (172)
Sponsored (50)
Startups (3900)
State (2)
Stomach cancer (19)
Supply chain (134)
Tariffs (90)
The Weekly (70)
Vaccines (1172)
Venture capital (116)
Weight loss (499)
Women's health (134)
Worklife (20)
Date
Today (144)
Last 7 days (763)
Last 30 days (3465)
Last 365 days (30960)
2026 (14516)
2025 (30906)
2024 (36099)
2023 (41142)
2022 (52382)
2021 (57097)
2020 (55908)
2019 (48792)
2018 (36935)
2017 (33744)
2016 (33563)
2015 (39608)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (819)
Alabama (95)
Alaska (7)
Arizona (367)
Arkansas (16)
Asia (43037)
Australia (7103)
California (13779)
Canada (3873)
China (1471)
Colorado (598)
Connecticut (618)
Delaware (427)
Europe (93927)
Florida (2054)
Georgia (449)
Hawaii (3)
Idaho (67)
Illinois (1160)
India (93)
Indiana (627)
Iowa (23)
Japan (569)
Kansas (136)
Kentucky (52)
Louisiana (45)
Maine (76)
Maryland (1677)
Massachusetts (9924)
Michigan (384)
Minnesota (762)
Mississippi (7)
Missouri (149)
Montana (33)
Nebraska (29)
Nevada (150)
New Hampshire (90)
New Jersey (3638)
New Mexico (31)
New York (3619)
North Carolina (1817)
North Dakota (9)
Northern California (6924)
Ohio (411)
Oklahoma (24)
Oregon (42)
Pennsylvania (2756)
Puerto Rico (29)
Rhode Island (53)
South America (1201)
South Carolina (88)
South Dakota (2)
Southern California (5448)
Tennessee (221)
Texas (2214)
United States (48987)
Utah (411)
Vermont (1)
Virginia (334)
Washington D.C. (84)
Washington State (1131)
West Virginia (4)
Wisconsin (139)
Wyoming (2)
770,954 Results for "miromatrix medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
United Therapeutics to Acquire Miromatrix Medical
United Therapeutics Corporation and Miromatrix Medical Inc. announced a definitive agreement for United Therapeutics to acquire Miromatrix.
October 30, 2023
·
9 min read
Deals
United Therapeutics and Miromatrix Medical Announce Successful Tender Offer
United Therapeutics Corporation and Miromatrix Medical Inc. announced the results of the previously announced tender offer by Morpheus Subsidiary Inc., a wholly owned subsidiary of United Therapeutics, to acquire all outstanding shares of Miromatrix.
December 12, 2023
·
5 min read
Deals
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger.
December 13, 2023
·
4 min read
Deals
Miromatrix Medical Inc. Announces Proposed Public Offering of Common Stock
Miromatrix Medical Inc. today announced that it has commenced an underwritten public offering of shares of its common stock.
March 7, 2023
·
5 min read
Press Releases
Avanos Medical, Inc. to Nominate James Cunniff and William Burke to Board of Directors
February 26, 2026
·
8 min read
Business
Miromatrix Reports Third Quarter 2023 Results
Miromatrix Medical Inc. (Nasdaq: MIRO) (the “Company”), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today reported third quarter 2023 financial results.
November 14, 2023
·
10 min read
Press Releases
Medical Care Technologies Inc. (OTC Pink:MDCE) Expands AI Commercialization Strategy with Enterprise Vision Solutions
May 11, 2026
·
2 min read
Press Releases
Tenon Medical, Inc. Sets Date for First Quarter 2026 Earnings
May 1, 2026
·
2 min read
BioMidwest
Miromatrix Medical Inc. Announces Pricing of $10 Million Public Offering of Common Stock
Miromatrix Medical Inc. (“Miromatrix”) (Nasdaq: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced the pricing of an underwritten public offering of 6,250,000 shares of its common stock at a price to the public of $1.60 per share, before underwriting discounts and commissions.
March 7, 2023
·
5 min read
BioMidwest
Miromatrix to Present at the 2023 ISODP Organ Donation Congress
Miromatrix Medical Inc. (NASDAQ: MIRO) today announced that it will be presenting at the 2023 International Society for Organ Donation and Procurement (“ISODP”) Organ Donation Congress in Las Vegas, NV on October 18-21 at Mandalay Bay Resort.
October 11, 2023
·
1 min read
1 of 77,096
Next
